ASLAN Pharmaceuticals

OverviewSuggest Edit

ASLAN Pharmaceuticals is a clinical-stage oncology-focused biotechnology company developing novel therapeutics for global markets. The Company targets diseases that are both highly prevalent in Asia and orphan indications in the United States and Europe.

TypePublic
HQSG
Websiteaslanpharma.com

Latest Updates

Employees (est.) (May 2021)18(-60%)
Share Price (May 2021)$2.6(-5%)
Cybersecurity ratingBMore

Key People/Management at ASLAN Pharmaceuticals

Carl Firth

Carl Firth

Chief Executive Officer
Stephen Doyle

Stephen Doyle

Chief Business Officer
Kenneth Kobayashi

Kenneth Kobayashi

Chief Medical Officer
Ben Goodger

Ben Goodger

General Counsel
Kiran Asarpota

Kiran Asarpota

Chief Operating Officer
Andrew Howden

Andrew Howden

Chairman
Show more

ASLAN Pharmaceuticals Office Locations

ASLAN Pharmaceuticals has an office in Collingwood
Collingwood, AU
58 Gipps St
Show all (4)

ASLAN Pharmaceuticals Financials and Metrics

ASLAN Pharmaceuticals Revenue

Market capitalization (12-May-2021)

183.5m

Closing stock price (12-May-2021)

2.6
ASLAN Pharmaceuticals's current market capitalization is $183.5 m.
Show all financial metrics

ASLAN Pharmaceuticals Cybersecurity Score

Cybersecurity ratingPremium dataset

B

80/100

SecurityScorecard logo

ASLAN Pharmaceuticals Online and Social Media Presence

Embed Graph

ASLAN Pharmaceuticals News and Updates

ASLAN Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update

 - Next data readout for ASLAN004 in the treatment of patients with moderate to severe atopic dermatitis anticipated in the third quarter of 2021 - Phase 2b clinical trial for ASLAN004 expected to initiate in the second half of 2021

ASLAN Pharmaceuticals to Present Data on ASLAN004 at Society for Investigative Dermatology

- ASLAN will give a poster presentation of new data from its Single Ascending Dose (SAD) study of ASLAN004, during the virtual event on 6 May, 2021

ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update

Next data readout for ASLAN004 in the treatment of patients with moderate to severe atopic dermatitis anticipated in the third quarter of 2021 Next data readout for ASLAN004 in the treatment of patients with moderate to severe atopic dermatitis anticipated in the third quarter of 2021

ASLAN Pharmaceuticals Appoints Dr Kathleen Metters as Independent Director

SINGAPORE, March 18, 2021 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN), a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced the appointment of Kathleen M. Metters, PhD, as an independent direc…

ASLAN Pharmaceuticals Announces Pricing of Public Offering of American Depositary Shares

SINGAPORE, March 03, 2021 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced the pricing of an underwritten public offering of 15,000,000 Americ…

ASLAN Pharmaceuticals Announces Positive Interim Data From the Multiple Ascending Dose Study of ASLAN004 in Atopic Dermatitis

- 74% average reduction in EASI from baseline at therapeutic doses after 8 weeks. 89% of patients achieved EASI-50 and 56% achieved EASI-90
Show more

ASLAN Pharmaceuticals Blogs

ASLAN Pharmaceuticals To Present Data On ASLAN004 At Society for Investigative Dermatology

ASLAN Pharmaceuticals (NASDAQ: ASLN), a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that an abstract on ASLAN004 has been accepted for poster presentation at the upcoming 2021 Society for Investigati…

ASLAN CEO Dr Carl Firth to participate at Jefferies Virtual Healthcare Conference 2021, 1-4 June, New York

The post ASLAN CEO Dr Carl Firth to participate at Jefferies Virtual Healthcare Conference 2021, 1-4 June, New York appeared first on ASLAN Pharmaceuticals.

ASLAN Pharmaceuticals Appoints Dr Kathleen Metters As Independent Director

ASLAN Pharmaceuticals (Nasdaq:ASLN), a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced the appointment of Kathleen M. Metters, PhD, as an independent director. Dr Metters has more than 30 years’ experien…

ASLAN Pharmaceuticals Announces Pricing of Public Offering of American Depository Shares

ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced the pricing of an underwritten public offering of 15,000,000 American Depositary Shares (“ADSs”) representing 75,00…

ASLAN Pharmaceuticals opens expansion cohort in ASLAN004 atopic dermatitis clinical trial

ASLAN Pharmaceuticals (Nasdaq:ASLN), a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that it has received approval from the Data Monitoring Committee (DMC) to initiate recruitment of patients into the …

ASLAN Pharmaceuticals to present at upcoming Piper Sandler investor conference

ASLAN Pharmaceuticals (Nasdaq:ASLN), a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced Dr Carl Firth, Chief Executive Officer of the company, will participate in a fireside chat at the Piper Sandler 32nd…
Show more

ASLAN Pharmaceuticals Frequently Asked Questions

  • Who are ASLAN Pharmaceuticals key executives?

    ASLAN Pharmaceuticals's key executives are Carl Firth, Stephen Doyle and Kenneth Kobayashi.

  • How many employees does ASLAN Pharmaceuticals have?

    ASLAN Pharmaceuticals has 18 employees.

  • Who are ASLAN Pharmaceuticals competitors?

    Competitors of ASLAN Pharmaceuticals include AstraZeneca, Telix Pharmaceuticals and ImmunSYS.

  • Where are ASLAN Pharmaceuticals offices?

    ASLAN Pharmaceuticals has an office in Collingwood.

  • How many offices does ASLAN Pharmaceuticals have?

    ASLAN Pharmaceuticals has 4 offices.